Goldman Sachs Group Inc Ars Pharmaceuticals, Inc. Comm Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Goldman Sachs Group Inc holds 275,855 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
275,855
Previous 440,739
37.41%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions